Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced today that it has established a local operating presence in Venezuela through a wholly owned subsidiary. The move is intended to support infrastructure development and the planned deployment of its telehealth and AI-powered healthcare analytics platforms in the region.
The subsidiary will facilitate the Company's evaluation of market opportunities, development of strategic partnerships, and implementation of healthcare technology solutions, including remote patient monitoring and AI-enabled analytics. Management believes this presence is a critical step in the Company's regional strategy, providing a foundation for pilot programs and collaboration with local healthcare providers.
Catalyst Crew Technologies' AI healthcare platform includes modular systems such as CardioAI, PulmoAI, and NeuroAI, which are designed to integrate into broader healthcare services infrastructure. The Company intends to prioritize market development in Latin America, where technology-enabled solutions may help expand access to medical services, improve diagnostic capabilities, and support more efficient healthcare delivery.
Dr. Kevin Rodan Levy, Chief Executive Officer, stated: "Establishing a local operating presence is an important step in executing our regional strategy. We believe that combining AI-driven healthcare technologies with localized healthcare infrastructure can support more accessible and efficient delivery of medical services."
For more information, visit https://catalystcrewai.com or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
